Showing results (61-70 of 234) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomasSilvia Hernández, Elena López-Knowles, Josep Lloreta, et al.
Environmental and Molecular Mutagenesis|March 28, 2009
Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinomaMarta Crous-Bou, Miquel Porta, Tomàs López, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Bladder Cancer Molecular Taxonomy: Summary from a Consensus MeetingSeth P Lerner, David J McConkey, Katherine A Hoadley, et al.
EMBO Molecular Medicine|August 19, 2015
AID-expressing epithelium is protected from oncogenic transformation by an NKG2D surveillance pathwayArantxa Pérez-García, Pablo Pérez-Durán, Thomas Wossning, et al.
International Journal of Proteomics|November 21, 2015
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal AdenocarcinomaAnna S Gerdtsson, Núria Malats, Anna Säll, et al.
Oncotarget|November 19, 2016
E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3Kβ silencingÁfrica Millán-Uclés, Susana Zuluaga, Miriam Marqués, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 31, 2014
Addressing the challenges of pancreatic cancer: future directions for improving outcomesManuel Hidalgo, Stefano Cascinu, Jörg Kleeff, et al.
Mutagenesis|October 3, 2009
In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutationsMiquel Porta, Tomàs López, José Pumarega, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expressionMarta Pascual, Ibane Abasolo, Ana Mingorance-Le Meur, et al.
Molecular Cancer Therapeutics|February 22, 2023
Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer ResistanceMiriam Marqués, Sonia Corral, María Sánchez-Díaz, et al.
Pageof 24